Top-News

Cardiome Pharma News

Keine aktuellen Kursdaten verfügbar
WKN: A1T824
ISIN: CA14159U3010
Typ: Aktie

Cardiome Pharma News

17.05.18 - PR Newswire
Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV
Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV PR Newswire
17.05.18 - PR Newswire
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China PR Newswire
15.05.18 - PR Newswire
Correvio Reports First Quarter 2018 Financial Results
Correvio Reports First Quarter 2018 Financial Results PR Newswire
15.05.18 - PR Newswire
Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals
Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals PR Newswire
10.05.18 - PR Newswire
Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call
Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call PR Newswire
26.04.18 - PR Newswire
Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference
Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference PR Newswire
17.04.18 - PR Newswire
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess® PR Newswire
12.04.18 - PR Newswire
Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018
Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018 PR Newswire
06.04.18 - PR Newswire
Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds
Cardiome Announces Amendment to Term Loan Agreement with CRG-​Managed Funds PR Newswire
28.03.18 - PR Newswire
Cardiome Announces Recent Insider Purchases
Cardiome Announces Recent Insider Purchases PR Newswire
22.03.18 - PR Newswire
Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review
Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review PR Newswire
20.03.18 - PR Newswire
Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome
Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome PR Newswire
13.03.18 - PR Newswire
Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results
Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results PR Newswire
06.03.18 - PR Newswire
Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13
Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13 PR Newswire
08.02.18 - PR Newswire
Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
23.01.18 - PR Newswire
Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen
Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen PR Newswire
10.01.18 - PR Newswire
Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit
Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit PR Newswire
12.12.17 - PR Newswire
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia PR Newswire
11.12.17 - PR Newswire
Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission
Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission PR Newswire
11.12.17 - PR Newswire
Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference
Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference PR Newswire

Newssuche

Videos

newspaper
25.04.24 +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »